Q2 2026 · Form 13F LedgerData source: SEC EDGAR  
H

HOLDER.TOP

Who owns what — the quarterly ledger of U.S. institutional holdings.
EN · 简 · 繁
Funds / Perceptive Advisors Llc
Form 13F · Q2 2026

Perceptive Advisors Llc

CIK 1224962Filed 2026-08-1413F-HR View the filing on EDGAR ↗
$6.7B
Reported book value
109
Positions
12
Quarters on record
Top 50
Positions

Perceptive Advisors Llc — holdings

Top 50 positions of 109, ranked by reported value. Share change is versus the previous quarter.
#SecuritySharesShare Δ QoQValue% of book
1PRAX Praxis Precision Medicines I2.0M+0.0%$682M10.2%
2SYRE Spyre Therapeutics Inc4.3M+14.2%$383M5.8%
3CELC Celcuity Inc3.2M+2.2%$334M5.0%
4ASND Ascendis Pharma A/S1.2M—$310M4.7%
5RYTM Rhythm Pharmaceuticals Inc2.6M+9.0%$287M4.3%
6ROIV Roivant Sciences Ltd8.1M−2.4%$286M4.3%
7RLAY Relay Therapeutics Inc14.1M+44.7%$264M4.0%
8TVTX Travere Therapeutics Inc3.8M−9.4%$213M3.2%
9KARD Kardigan Inc8.2M—$196M2.9%
10NUVALENT INC Nuvalent Inc1.6M+0.0%$195M2.9%
11EWTX Edgewise Therapeutics Inc4.4M−1.1%$178M2.7%
12APOGEE THERAPEUTICS INC Apogee Therapeutics Inc1.3M−15.1%$174M2.6%
13AMLX Amylyx Pharmaceuticals Inc8.3M+0.6%$150M2.2%
14MGTX Meiragtx Hldgs Plc10.8M+4.5%$146M2.2%
15ORKA Oruka Therapeutics Inc1.3M−3.6%$128M1.9%
16INBX Inhibrx Biosciences Inc1.3M−10.0%$123M1.8%
17PTGX Protagonist Therapeutics Inc981,879−20.2%$120M1.8%
18SLDB Solid Biosciences Inc11.9M+0.0%$119M1.8%
19ZYME Zymeworks Inc4.2M+19.2%$109M1.6%
20TNGX Tango Therapeutics Inc3.4M+317.9%$106M1.6%
21IMTX Immatics N.V10.4M+0.0%$105M1.6%
22NRIX Nurix Therapeutics Inc4.3M+16.4%$105M1.6%
23BCRX Biocryst Pharmaceuticals Inc10.3M+38.7%$103M1.5%
24RVMD Revolution Medicines Inc527,600+104.0%$99M1.5%
25AVALYN PHARMACEUTICALS INC Avalyn Pharmaceuticals Inc2.7M—$88M1.3%
26DYN Dyne Therapeutics Inc2.7M−42.4%$60M0.9%
27BIIB Biogen Inc276,173—$60M0.9%
28IMVT Immunovant Inc1.4M−15.0%$52M0.8%
29UNH Unitedhealth Group Inc116,806—$49M0.7%
30IONS Ionis Pharmaceuticals Inc566,000+12.3%$45M0.7%
31STRO Sutro Biopharma Inc1.3M+82.4%$43M0.7%
32ANRO Alto Neuroscience Inc1.6M−19.9%$42M0.6%
33JAZZ Jazz Pharmaceuticals Plc170,000+0.0%$41M0.6%
34CRVS Corvus Pharmaceuticals Inc2.7M+16.4%$40M0.6%
35SION Sionna Therapeutics Inc905,000+37.4%$40M0.6%
36CTMX Cytomx Therapeutics Inc.10.4M+3.4%$39M0.6%
37AORT Artivion Inc1.7M+6.1%$39M0.6%
38XFOR X4 Pharmaceuticals Inc7.9M+17.7%$37M0.6%
39CORT Corcept Therapeutics Inc398,385+696.8%$35M0.5%
40RGEN Repligen Corp248,212−11.5%$34M0.5%
41AVR Anteris Technologies Global3.4M+0.0%$34M0.5%
42RAPP Rapport Therapeutics Inc773,342+14.8%$32M0.5%
43DMRA Damora Therapeutics Inc1.2M+0.0%$32M0.5%
44CHARLES RIV LABS INTL INC Charles Riv Labs Intl Inc140,000—$32M0.5%
45AXSM Axsome Therapeutics Inc.118,450−21.0%$29M0.4%
46DBVT Dbv Technologies S A1.7M+71.4%$27M0.4%
47IRTC Irhythm Holdings Inc223,766+113.1%$27M0.4%
48ADPT Adaptive Biotechnologies Cor1.2M+698.2%$26M0.4%
49SABS Sab Biotherapeutics Inc6.6M+3.0%$26M0.4%
50DANAHER CORP DEL Danaher Corp Del130,000—$25M0.4%
Source: Form 13F filings via SEC EDGAR. Positions as of Jun 30, 2026. Options (put/call) are excluded from share counts.